Symetryx Corp, 10% Owner at NeuBase Therapeutics, Inc. (NBSE), sold 514,890 shares at $1.19 ($692K) on 2023-09-18, disclosed to the SEC on 2023-09-18.
Open-market sale of $692k NBSE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.44 | 129,108 | $186K | 26.9% |
| 2 | $1.44 | 129,108 | $186K | 26.9% |
| 3 | $1.26 | 103,337 | $130K | 18.8% |
| 4 | $1.26 | 103,337 | $130K | 18.8% |
| 5 | $1.19 | 50,000 | $60K | 8.6% |
| Total | $1.34 avg | 514,890 |
| $692K |
| 100% |
| Filing → |